TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF EUROPE SMART CONTACT LENS MARKET 14
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 16
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 CURRENCY AND PRICING 20
2.5 DBMR TRIPOD DATA VALIDATION MODEL 21
2.6 MULTIVARIATE MODELLING 24
2.7 DESIGN LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 MARKET APPLICATION COVERAGE GRID 27
2.11 SECONDARY SOURCES 28
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 32
4.1 PORTERS FIVE FORCES 33
4.2 PESTEL ANALYSIS 34
4.3 INDUSTRIAL INSIGHTS: 35
4.4 CONCLUSION: 35
5 EUROPE SMART CONTACT LENS MARKET: REGULATIONS 36
6 MARKET OVERVIEW 39
6.1 DRIVERS 41
6.1.1 INCREASE IN PREVALENCE OF REFRACTIVE ERROR 41
6.1.2 RISING CASES OF DIABETIC RETINOPATHY 42
6.1.3 INCREASING R&D ACTIVITIES BY KEY MARKET PLAYERS FOR SMART CONTACT LENS 42
6.1.4 RISE IN THE PREVALENCE OF EYE DISORDER 43

6.2 RESTRAINTS 43
6.2.1 INCREASING SIDE EFFECTS ASSOCIATED WITH CONTACT LENSES 43
6.2.2 GROWING ACCEPTANCE OF REFRACTIVE SURGERIES 44
6.3 OPPORTUNITIES 44
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN CONTACT LENSES 44
6.3.2 INCREASING PREFERENCE FOR CONTACT LENSES INSTEAD OF EYEGLASSES 45
6.4 CHALLENGES 45
6.4.1 SAFETY CONCERNS ASSOCIATED WITH THE USE OF CONTACT LENSES 45
6.4.2 STRICT REGULATIONS AND STANDARDS FOR APPROVAL OF CONTACT LENSES 46
7 EUROPE SMART CONTACT LENS MARKET, BY DESIGN 47
7.1 OVERVIEW 48
7.2 MICROLED DISPLAY CONTACT LENS 51
7.3 DIAGNOSTIC SENSOR INTEGRATED CONTACT LENS 51
7.4 PHOTODETECTOR CONTACT LENSES 52
7.5 DRUG ELUDING CONTACT LENS 52
7.6 ELECTROCHEMICAL CONTACT LENS SENSORS 53
7.7 LIGHT DIFFRACTIVE CONTACT LENSES 53
7.8 FLUORESCENCE-BASED CONTACT LENSES 54
7.9 OTHERS 55
8 EUROPE SMART CONTACT LENS MARKET, BY MATERIAL 56
8.1 OVERVIEW 57
8.2 GRAPHENE 60
8.3 HYDROGEL CONTACT LENSES 60
8.4 CONDUCTING POLYMERS 61
8.5 HYBRID CONTACT LENSES 61
8.6 METAL NANOWIRES 62
8.7 CARBON NANOTUBES 62
8.8 INORGANIC MAGNETIC OXIDE NANOSHEETS 63
8.9 METAL-MESH STRUCTURES 63
8.10 PEPTIDE MODIFIED GOLD NANOBOWL (AUNBS) 64
9 EUROPE SMART CONTACT LENS MARKET, BY APPLICATION 65
9.1 OVERVIEW 66
9.2 DIABETES/CONTINUOUS GLUCOSE MONITORING/GLAUCOMA 69
9.3 INTRAOCULAR PRESSURE MONITORING 69
9.4 FARSIGHTEDNESS 70
9.5 EYE HEALTH MONITOR 71
9.6 CATARACTS 71
9.7 DRUG DELIVERY 72
9.8 NIGHT VISION 72
9.9 OTHERS 73
10 EUROPE SMART CONTACT LENS MARKET, BY END USER 74
10.1 OVERVIEW 75
10.2 CLINICS 78
10.3 HOSPITALS 78
10.4 HOME CARE SETTINGS 79
10.5 OTHERS 79
11 EUROPE SMART CONTACT LENS MARKET, BY DISTRIBUTION CHANNEL 80
11.1 OVERVIEW 81
11.2 CLINICS 84
11.3 RETAIL STORES 84
11.4 E-COMMERCE 85
11.5 HOSPITALS 86
12 EUROPE SMART CONTACT LENS MARKET, BY REGION 87
12.1 EUROPE 88
12.1.1 GERMANY 95
12.1.2 U.K. 97
12.1.3 ITALY 99
12.1.4 SPAIN 101
12.1.5 SWITZERLAND 103
12.1.6 POLAND 105
12.1.7 AUSTRIA 107
13 COMPANY PROFILE 109
13.1 SENSIMED AG 109
13.1.1 COMPANY SNAPSHOT 109
13.1.2 PRODUCT PORTFOLIO 109
13.1.3 RECENT DEVELOPMENT 109
13.1.3.1 PMDA Approval 109
13.2 APPLE INC. 110
13.2.1 COMPANY SNAPSHOT 110
13.2.2 REVENUE ANALYSIS 110
13.2.3 PRODUCT IN PIPELINE 111
13.2.4 RECENT DEVELOPMENT 111
13.2.4.1 PRODUCT DEVELOPMENT 111

13.3 GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJI SAN. VE TIC. A.. 112
13.3.1 COMPANY SNAPSHOT 112
13.3.2 PRODUCT IN PIPELINE 112
13.3.3 RECENT DEVELOPMENT 112
13.3.3.1 PRODUCT LAUNCH 112
13.4 INNOVEGA INC., 113
13.4.1 COMPANY SNAPSHOT 113
13.4.2 PRODUCT IN PIPELINE 113
13.4.3 RECENT DEVELOPMENT 113
13.4.3.1 PATENT 113
13.5 INWITH CORP 114
13.5.1 COMPANY SNAPSHOT 114
13.5.2 PRODUCT IN PIPELINE 114
13.5.3 RECENT DEVELOPMENT 114
13.5.3.1 PATENT ANALYSIS 114
13.6 MEDIPRINT 115
13.6.1 COMPANY SNAPSHOT 115
13.6.2 PRODUCT IN PIPELINE 115
13.6.3 RECENT DEVELOPMENT 115
13.6.3.1 PATENT ANALYSIS 115
13.7 MICROSOFT 116
13.7.1 COMPANY SNAPSHOT 116
13.7.2 REVENUE ANALYSIS 116
13.7.3 PRODUCT IN PIPELINE 117
13.7.4 RECENT DEVELOPMENT 117
13.7.4.1 PRODUCT DEVELOPMENT 117
13.8 MOJO VISION INC., 118
13.8.1 COMPANY SNAPSHOT 118
13.8.2 PRODUCT PORTFOLIO 118
13.8.3 RECENT DEVELOPMENT 118
13.8.3.1 PARTNERSHIP 118
13.9 OCUMEDIC, INC., 119
13.9.1 COMPANY SNAPSHOT 119
13.9.2 PRODUCT IN PIPELINE 119
13.9.3 RECENT DEVELOPMENT 119
13.9.3.1 PARTNERSHIP 119
13.10 RAAYONNOVA LLC 120
13.10.1 COMPANY SNAPSHOT 120
13.10.2 PRODUCT IN PIPELINE 120
13.10.3 RECENT DEVELOPMENT 120
13.10.3.1 PATENT 120
13.11 SAMSUNG 121
13.11.1 COMPANY SNAPSHOT 121
13.11.2 REVENUE ANALYSIS 121
13.11.3 PRODUCT IN PIPELINE 122
13.11.4 RECENT DEVELOPMENT 122
13.11.4.1 PATENT GRANT 122
13.12 SONY CORPORATION 123
13.12.1 COMPANY SNAPSHOT 123
13.12.2 REVENUE ANALYSIS 123
13.12.3 PRODUCT IN PIPELINE 124
13.12.4 RECENT DEVELOPMENT 124
13.12.4.1 PRODUCT DEVELOPMENT 124
13.13 STMICROELECTRONICS 125
13.13.1 COMPANY SNAPSHOT 125
13.13.2 REVENUE ANALYSIS 125
13.13.3 PRODUCT IN PIPELINE 126
13.13.4 RECENT DEVELOPMENT 126
13.13.4.1 PARTNERSHIP 126
14 RELATED REPORTS 127

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.